Femoral arterial puncture site closure for diagnostic angiography or interventional procedures
Suture, collagen, and anchor sandwich of the arteriotomy; all components reabsorb within 90 days; FDA labeling for immediate restick; FDA labeling for 20-minute ambulation and 60-minute discharge for diagnostic cases with a 6-F sheath or smaller procedural sheath
Cordis
Exoseal Vascular Closure Device
Extravascular PGA plug
5, 6, 7
Uses existing procedural sheath
Femoral artery puncture site closure
Precise extravascular positioning with unique lockout mechanism and visual indicators to help prevent intravascular deployment; this device does not require assembly and is deployed via a simple three-step process; the PGA plug is fully resorbed as carbon dioxide and water within 60–90 days
Inari Medical
FlowStasis Suture Retention Device
Suture retention
28
0.035
Temporary suture retention following a percutaneous venous procedure
–
Teleflex
Manta Vascular Closure Device
Bioresorbable implant
Following the use of 10–20 F device or sheaths (12–25 F OD)
0.035
Indicated for closure of femoral artery access sites while reducing time to hemostasis following the use of 10–20-F devices or sheaths (12–25-F OD) in endovascular catheterization procedures
Designed specifically for closure of large bore femoral artery access sites; easy positioning without the need for preclosure; simple deployment with help from auditory and visual cues and a reliable closure using a single device
Cordis
Mynx Control Vascular Closure Device
Extravascular PEG sealant
5, 6, 7
Uses existing procedural sheath
Femoral arteries
Integrates dual-mode active sealing and resorbability with a next-generation delivery system to maximize predictability, safety, and ease of use
Cordis
MynxGrip Vascular Closure Device
Extravascular PEG sealant
5, 6, 7
Uses existing procedural sheath
Femoral arteries and veins
Indicated for femoral arteries and veins; provides secure mechanical closure with the safety of an extravascular sealant; the Grip sealant actively adheres to and seals the arteriotomy or venotomy while expanding to fill the tissue tract; offers a patient-friendly closure option that is completely extravascular and dissolves within 30 days
Abbott
Perclose ProGlide
Suture
Common femoral artery 5–21 (max OD 26), common femoral vein 5–24 (max OD 29)
0.038
Common femoral artery (5–21 F) and vein (5–24 F) access sites
Provides secure repair with pre-tied polypropylene monofilament suture, ability to maintain wire access, minimal intravascular footprint with no re-access restrictions; broadest indication for both femoral arterial and venous access
Abbott
Prostar XL
Suture
8.5–10
0.038
Common femoral artery (8.5–10 F) access sites
Provides secure repair with two braided sutures, ability to maintain wire access with minimal intravascular footprint
Ensite Vascular
SiteSeal
External compression
Common femoral artery 5–21 (max OD, 26), common femoral vein 5–24 (max OD, 29)
Utilizes existing procedural sheath
Compression of the femoral artery or vein after vessel cannulation
A simple-to-deploy single device that closes multiple sheaths of any size, leaving nothing behind; it is indicated for both arterial and venous access
Abbott
StarClose SE
Nitinol clip
5–6
0.038
Common femoral artery (5–6 F) access sites
Utilizes an extravascular nitinol clip to provide immediate repair, simple to use; hemostasis can be challenged and confirmed on the table
Haemonetics
Vascade MVP Venous Vascular Closure System (VVCS)
Extravascular, bioabsorbable closure device
6–12 inner diameter (up to 15 maximum outer diameter)
Utilizes existing procedural sheath
Femoral venous access sites: 6–12-F inner diameter (up to 15-F maximum outer diameter)
Fully integrated, extravascular, bioabsorbable femoral venous closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in the AMBULATE trial, a prospective, multicenter, randomized clinical trial comparing Vascade MVP to manual compression; the Vascade MVP system combines Cardiva’s proven proprietary collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design; a multiaccess site indication is required for vascular closure devices to provide hemostasis in procedures that require more than one access site in the same vessel such as cardiac ablations (Vascade MVP venous vascular closure system is indicated for this use)
Haemonetics
Vascade Vascular Closure System (VCS)
Extravascular, bioabsorbable closure device
5, 6, 7
Utilizes existing procedural sheath
Femoral arterial and femoral venous access sites (5, 6, or 7 F)
Fully integrated, extravascular, bioabsorbable femoral access closure system that is easy to use, leaves no permanent components behind, and has demonstrated safety and efficacy in the RESPECT trial, a prospective, multicenter, randomized clinical trial comparing Vascade to manual compression; the system combines Cardiva’s proven proprietary collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design; it enables rapid hemostasis while minimizing complications
Advertisement
Advertisement
We value keeping the Device Guide up to date.
If you want to add or update your company’s device listings, please let us know!